“America will never be a socialist nation,” President Trump proudly proclaimed in his 2019 State of the Union Address. Sadly, as each day of this coronavirus pandemic wears on, these words seem to grow less and less prophetic. Just as we think we’ve reached our capacity for government intrusions into the daily lives of Americans, we’re reminded that we may not have even scraped the surface.

The Wall Street Journal claims that Bernie Sanders will increase federal taxes to the highest levels since World War II to pay for all of Sanders’ socialist promises:

During a recent interview with Anderson Cooper on 60 Minutes, Democratic frontrunner Bernie Sanders (I-Vt.) once again showed his true colors when asked about his vocal support for Cuban despot Fidel Castro. “It’s unfair to simply say everything is bad,” Sanders said. “When Fidel Castro came into office, you know what he did? He had a massive literacy program. Is that a bad thing? Even though Fidel Castro did it?”

As the race for the White House continues to ramp up, the Democratic primary appears to have split fairly cleanly between two camps. The more moderate candidates -- led by Former Vice President Joe Biden -- form one contingent, and the self-described “progressives” -- championed by Sen. Elizabeth Warren(D-Mass.) and Sen. Bernie Sanders (I-Vt.) -- form the other. While the moderate candidates have mostly stuck with a more traditional democratic platform, Warren and Sanders have led a significant portion of the caucus into a headlong plunge off the deep end.

FreedomWorks is proud to announce that our bill of the month for August 2019 is the anti-socialism resolution, S.Res. 289, introduced by Sen. Steve Daines (R-Mont.), which expresses “the sense of the Senate that socialism poses a significant threat to freedom, liberty, and economic prosperity.”

FreedomWorks’ activist-chosen dumpster fire of the month for May 2019 is the Transparent Drug Pricing Act, S. 977. Introduced by Rep. Rick Scott (R-FL), this is yet another proposal targeted at reducing prescription drug prices in America based on the faulty logic of international price controls. Among other substantive changes to public health regulations, S. 977 would mandate that U.S. prescription drug prices “may not exceed the lowest retail list price for the drug among Canada, France, the United Kingdom, Japan, or Germany.”